"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"

Affiliations

• ¹ School of Medical Sciences, Örebro University, Örebro, Sweden.
• ² Department of Human Genetics, Hannover Medical School, Hannover, Germany.
• ³ Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁴ Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
• ⁵ Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
• ⁶ Section for Hematology and Coagulation, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
• ⁷ Department of Hematology, Oslo University Hospital, Oslo, Norway.
• ⁸ Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
• ⁹ Department of Medical Science, Section of Hematology, Uppsala University, Uppsala, Sweden.
• ¹⁰ Department of Medical Biosciences, Umeå University, Umeå, Sweden.
• ¹¹ Department of Internal Medicine, Falun General Hospital, Falun, Sweden.
• ¹² Department of Hematology, Odense University Hospital, Odense, Denmark.
• ¹³ Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine (HERM), Karolinska Institutet, Stockholm, Sweden.
• ¹⁴ Clinical Genomics Facility, Uppsala, Science for Life Laboratory IGP, Rudbeck Laboratory, Uppsala University and Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden.
• ¹⁵ Department of Medicine, Division of Hematology, Helsinki University Central Hospital, Helsinki, Finland.
• ¹⁶ Division for Hematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
• ¹⁷ Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
• ¹⁸ Department of Clinical Pathology, Division of Hematopathology, Karolinska University Hospital and Institute, Solna, Stockholm, Sweden.
• ¹⁹ Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. eva.hellstrom-lindberg@ki.se.